Vascular risk factors in primary open angle glaucoma;Factores de riesgo vascular en el glaucoma primario de ángulo abierto

Anales del Sistema Sanitario de Navarra

Volumn 27, Issue 3, 2004, Pages 335-344

  Belzunce, Arnaldo ^a,c   Casellas, M ^b  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b Servicio de Dermatología   (Spain)

^c NONE   (Spain)

Author keywords

Glaucomatous optic neuropathy; Intraocular pressure; Optic nerve head ischaemia; Primary open angle glaucoma

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRINZOLAMIDE; DORZOLAMIDE; LATANOPROST; PILOCARPINE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSIS RELATED GROUP; DISEASE ASSOCIATION; DRUG CONTRAINDICATION; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; ISCHEMIC HEART DISEASE; MALE; OPEN ANGLE GLAUCOMA; PNEUMONIA; RAYNAUD PHENOMENON; RESPIRATORY TRACT DISEASE; STROKE; TOBACCO; AGED; CROSS-SECTIONAL STUDY; RISK FACTOR; VASCULAR DISEASE;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; RISK FACTORS; VASCULAR DISEASES;

EID: 11844271464     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. QUIGLEY HA. Number of people with glaucoma worlwide. Br J Opthalmol 1996; 80: 389-393.
2. GARCÍA FEIJOO J, MEZA SORIA JM. El Glaucoma. En: Sociedad Española de Oftalmología. Editor. ¿España ve bien? Campaña de prevención visual. ONCE 1999.
3. o ed. Philadelphia: W B Saunders Company 2000; IV; 2683.
4. The ocular hypertension treatment study. A randomized trial determines that ocular hypotensive medication delays the onset of POAG. Arch Opthalmol 2002; 120: 701-703.
5. HEILJ A, LESKE MC, BENGTSSON B, HYMAN L, HUSSEIN M for the Early Manifiest Glaucoma Trial Group. Reduction of Intraocular Pressure and Glaucoma Progression. Results from the Early Manifest Glaucoma Trial. Arch Opthalmol 2002; 120: 1268-1279.
6. CHUNG HS, HARRIS A, EVANS DW, KAGEMAN L, GARZOZI HJ, MARTIN B. Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv Opthalmol 1999; 43: S 43-50.
7. HAYREH SS. The role of age and cardiovascular disease in Glaucomatos Optic Neuropathy. Surv Opthalmol 1999; 43: S27-S42.
8. BENITEZ DEL CASTILLO J. La importancia de la dinámica de perfusión ocular en el glaucoma. Drugs Today 2000; 36: 1-3.
9. HAYREH SS. Factors determining the glaucomatous optic nerve head damage. En: Krieglestein GK editor: Glaucoma update III. Heidelberg. Springer-Verlag 1987: 40-46.
10. HAYREH SS, PE'ER J, ZIMMERMAN MB. Morphological changes in chronic high pressure experimental glaucoma in rhesus monkeys. J Glaucoma 1999; 8: 56-71.
11. KALMAL D, HITCHINSGS R. Normal tensión glaucoma-a practical approach. Br J Opthalmol 1998; 82: 835-840.
12. ELWYN H. Calcified carotid artery with atrophy of the optic nerve, cupping, and low tensión. Arch Ophthalmol 1940; 24: 476-478.
13. MILLER S. The enigma of glaucoma simples. Trans Ophthalmol Soc UK 1972; 92: 561-584.
14. RANKIN SJ, WALMAN BE, BUCKLEY AR, DRANCE SM. Colour doppler imaging and spectral analisis of the optic nerve vasculature in glaucoma. Am J Opthalmol 1995; 119: 685-693.
15. LEIGHTON DA, PHILLIPS C. Systemic blood pressure in open angle glaucoma, low tensión glaucoma, and the normal eye: Br J Opthalmol 1972; 56: 447-453.
16. WILSON MR, HERTZMARK E, WALKER AM, CHILDS-SHAW K, EPSTEIN DL. A case-control study of risk factors in open glaucoma. Arch Opthalmol 1987; 105: 1066-1071.
17. LESKE MC, PODGOR MJ. Intraocular pressure, cardiovascular risk variables, and visual field defects. Am J Epidemiol 1983; 118: 280-287.
18. DRANCE SM, SWEENEY VP, MORGAN RW, FELDMAN F. Studies of factors involved in the production of low tension glaucoma. Arch Opthalmol 1973; 89: 457-465.
19. DRANCE SM, SCHULZER M, DOUGLAS GR, SWEENEY VP. Use of discriminant analisis: II. Identification of persons with glaucomatous visual field defects. Arch Opthalmol 1978; 96: 1571-1573.
20. HARRIS A, CHUNG HS, KAGEMAN L, CANTOR L, MARTÍN B. A comparative study of betaxolol and dorzolamida effect on ocular circulation in normal tension glaucoma patients. Opthalmology. 2000; 107: 430-434.
21. RULO AH, GREVE EL, GEIJSSEN HC, HOYNG FJ. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma. Opthalmology 1996; 103: 1276-1282.
22. HART WM. The epidemiology of primary open angle glaucoma and ocular hypertension. En: Ritch R, Shields MB. The Glaucomas. St. Louis: CV Mosby 1959.